Firms
Theme

MCY

Mercury General Corp. · NYSE

News

7 latest

Zacks Investment Research

Why Mercury General (MCY) is a Top Momentum Stock for the Long-Term

Mercury General Corporation (MCY), a Los Angeles-based insurance holding company founded in 1961, has received a Zacks Rank #1 (Strong Buy) rating with a VGM Score of B. The company, which primarily writes personal automobile insurance with approximately 60% of its $6 billion in direct premiums, has seen two analysts revise earnings estimates higher in the last 60 days, with the Zacks Consensus Estimate increasing to $13.25 per share. MCY demonstrates strong momentum with a B Momentum Style Score and shares up 0.5% over the past four weeks, along with an impressive average earnings surprise of +70.2%.

Zacks Investment Research

Best Value Stocks to Buy for October 12th

Three stocks with Zacks Rank #1 and strong value characteristics are highlighted for investors: Mercury General Corporation (personal auto insurance), Equinor ASA (energy), and Woodside Energy Group Ltd (oil and gas exploration). All three companies have seen earnings estimate increases over the last 60 days and possess Value Scores of A, with P/E ratios below their respective industry averages.

Mentions MCY

Zacks Investment Research

American Express Q3 Earnings Beat Estimates on Strong Card Fees

American Express reported Q3 2026 adjusted EPS of $4.68, beating estimates by 4.7% with 13% year-over-year growth. Total revenues grew 9% to $20.1 billion, driven by increased Card Member spending, higher net interest income, and improved card fees. The company raised its 2026 GAAP EPS guidance to $18.30-$18.60 and reaffirmed 10% revenue growth expectations.

Zacks Investment Research

Aon Expands Ukraine War Risk Insurance Facility With EBRD Support

Aon and the European Bank for Reconstruction and Development have expanded their Ukraine Recovery and Reconstruction Guarantee Facility, increasing guarantee capacity to €150 million from €110 million. The program has facilitated over €500 million in reinsurance coverage through nearly 10,000 policies and now includes additional local insurers and expanded coverage for gas assets and temporary warehouse inventory.

Zacks Investment Research

New Strong Buy Stocks for October 12th

Five stocks have been added to the Zacks Rank #1 (Strong Buy) list, driven by increasing earnings estimates over the last 60 days. The stocks span energy, manufacturing, entertainment, insurance, and retail sectors, with earnings estimate increases ranging from 10% to 15.4%. The market is focused on upcoming CPI and PPI inflation reports and the start of Q3 earnings season.

Zacks Investment Research

Here's Why Investors Should Stay Neutral on AMSF Stock for Now

AMERISAFE (AMSF) has posted nine consecutive quarters of premium growth with voluntary premiums up 5.7% and renewal retention above 93%, supported by disciplined underwriting in high-hazard industries. However, the stock has underperformed significantly, declining 30.6% in three months.

Zacks Investment Research

THG Outperforms Industry, Trades at a Premium: Time to Buy or Exit?

The Hanover Insurance Group (THG) reported strong Q2 2026 results with net premiums written rising 4.4% and Personal Lines combined ratio improving 290 basis points to 81.9%. The company's pricing continues to exceed loss-cost trends, net investment income rose 13.4%, and ROE remains above 20%. THG has outperformed peers and the industry, gaining 26% in three months, with analysts suggesting 9.3% upside potential.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $MCY · 0 threads

Sign in to post on $MCY

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev